Results 201 to 210 of about 103,495 (263)

Stress native mapping does not distinguish patients with previous myocardial infarction with non‐obstructive coronary arteries from healthy volunteers

Clinical Physiology and Functional Imaging, Volume 46, Issue 4, July 2026.
Abstract Aims Patients with myocardial infarction with non‐obstructive coronary arteries (MINOCA) may be affected by coronary microvascular dysfunction with reduced stress perfusion. Changes in native T1 and T2 reflect changes in myocardial perfusion; therefore, the aim of our study was to investigate whether non‐contrast, adenosine stress native T1 ...
Daniel F. Andersson, Rebecka Steffen Johansson, Per Tornvall, Peder Sörensson, Jannike Nickander   +4 more
wiley   +1 more source

Association of long cardiac troponin T forms with adverse long-term outcomes in patients with advanced chronic kidney disease. [PDF]

BMC Nephrol
Salonen S, Kaipainen E, Hakamäki M, Liuhto N, Manni N, Toukola T, Virtanen J, Lankinen R, Metsärinne K, Vasankari T, Airaksinen KEJ, Järvisalo MJ, Wittfooth S, Hellman T.   +13 more
europepmc   +1 more source

Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review

Obesity Reviews, Volume 27, Issue 7, July 2026.
ABSTRACT Obesity as a chronic and multifactorial disease requires a multidisciplinary team acting together in a holistic multitarget intervention. Multidisciplinary therapy targeting obesity and its complications includes physical exercise, nutritional, and behavior counseling.
Ana Raimunda Dâmaso, Flávia Campos Corgosinho, Deborah Cristina Landi Masquio, Nayra Figueiredo, Fabiana Kattah, Cintia Cercato, Lian Tock, Raquel Munhoz da Silveira Campos   +7 more
wiley   +1 more source

Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy. [PDF]

JACC CardioOncol
Cheng E, Ivanovic M, Chan A, Xu S, Franquiz M, Lee C, You J, Fazal M, Le Guen Y, Batchelder R, Reddy SA, Katsumoto T, Ramchandran K, Colevas AD, Kahn S, Fan A, Wakelee H, Cheng P, Lewis EF, Wu SM, Witteles R, Neal J, Waliany S, Zhu H.   +23 more
europepmc   +1 more source

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender, Lauren Pommert, Lori R. Backus, Andrea Bidwell, Courtney Blank, Erin H. Breese, Karen C. Burns, Adam Lane, Lynn H. Lee, Benjamin Mizukawa, Robin E. Norris, Maureen M. O'Brien, Daniel Peck, Christine Phillips, Thomas D. Ryan, Jennifer Young, Michael Absalon, John P. Perentesis   +17 more
wiley   +1 more source

Cardiac Troponin Is Infrequently Tested at Emergency Department Visits With Suspected Acute Ischemic Stroke. [PDF]

J Am Heart Assoc
Kolludra K, Merkler A, Navi BB, Kamel H, Pawar A, Lanphier L, Liberman AL.   +6 more
europepmc   +1 more source

Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial. [PDF]

Open Forum Infect Dis
Pfeiffer S, Rhee M, Striplin S, Urdaneta V, Straus W, Wang X, Girard B, Priddy F, Chalkias S.   +8 more
europepmc   +1 more source

Cardiac Troponin I Antibodies Induce Cardiomyocyte Damage and Alter Cell Morphology. [PDF]

Int J Mol Sci
Furkel J, Zirkenbach VA, Knoll M, Öttl R, Rein K, Abdollahi A, Frey N, Konstandin MH, Kaya Z.   +8 more
europepmc   +1 more source